PaxMedica (PXMD) News Today → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free PXMD Stock Alerts $0.74 +0.04 (+5.72%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcastfinance.yahoo.com - April 26 at 9:43 AMUrgent Action: PaxMedica (NASDAQ: PXMD) Addresses Medical Crisis in Malawitheglobeandmail.com - April 25 at 1:41 PMPaxMedica (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDAtheglobeandmail.com - April 25 at 2:09 AMPaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101globenewswire.com - April 23 at 8:30 AMPaxMedica, Inc.: PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sicknessfinanznachrichten.de - April 18 at 10:59 PMPaxMedica, Inc.: PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submissionfinanznachrichten.de - April 12 at 11:57 PMNasdaq Down 300 Points; BlackRock Posts Upbeat Earningsmarkets.businessinsider.com - April 12 at 6:52 PMPenny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Ralliesmsn.com - April 12 at 1:50 PMWhy Is PaxMedica (PXMD) Stock Up 93% Today?investorplace.com - April 12 at 8:06 AMWhy Is PaxMedica (PXMD) Stock Up 93% Today?investorplace.com - April 12 at 7:51 AMPaxMedica shares soar 125% post-market on drug updatemsn.com - April 11 at 5:55 PMPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submissionfinance.yahoo.com - April 11 at 5:55 PMPaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submissionglobenewswire.com - April 11 at 4:30 PMPaxMedica (NASDAQ: PXMD) Developing Robust Product Lineup to Address ASD, Associated Conditionstheglobeandmail.com - April 9 at 12:48 PMPaxMedica (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patientstheglobeandmail.com - March 23 at 6:45 PMPaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatmentsglobenewswire.com - March 13 at 8:20 AMPaxMedica Inc Ordinary Shares PXMDmorningstar.com - March 6 at 4:40 PMPaxMedica Stock (NASDAQ:PXMD), Short Interest Reportbenzinga.com - February 23 at 1:33 AMPaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASDtheglobeandmail.com - January 29 at 12:42 PMIBN Highlights PaxMedica's Video Release on Transformative ASD Studyfinance.yahoo.com - January 18 at 10:07 AMIBN Highlights PaxMedica’s (NASDAQ: PXMD) Video Release on Transformative ASD Studytheglobeandmail.com - January 17 at 1:35 PMPaxMedica on Promising Path to Address Unmet ASD Needsfinance.yahoo.com - January 17 at 1:35 PMPaxMedica Files 8-K Following Nasdaq Compliance Achievementfinance.yahoo.com - December 22 at 5:12 PMPaxMedica, Inc. (PXMD) Interactive Stock Chart - Yahoo Financefinance.yahoo.com - December 20 at 9:01 AMPaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy Pipelinefinance.yahoo.com - December 19 at 12:59 PMPaxMedica Inc. Covered in H.C. Wainwright & Co. Research Reportfinance.yahoo.com - December 12 at 4:36 PMPaxMedica CEO Featured in Just-Released Fireside Chat Videofinance.yahoo.com - December 8 at 1:22 PMPaxMedica Releases Fireside Chat Video with CEO Howard Weismanfinance.yahoo.com - December 6 at 8:54 AMHC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy Recommendationmsn.com - December 5 at 8:50 AMPaxMedica Stock (NASDAQ:PXMD), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 4 at 8:47 PMPaxMedica Closes on Public Offering Reaching Estimated $7Mfinance.yahoo.com - December 1 at 2:21 PMPaxMedica Announces Closing of $7.0 Million Public Offeringfinance.yahoo.com - November 25 at 1:16 PMPaxMedica, Inc.: PaxMedica Announces Closing of $7.0 Million Public Offeringfinanznachrichten.de - November 22 at 6:34 PMPaxMedica Announces Pricing of $7M Public Offeringfinance.yahoo.com - November 22 at 1:34 PMWhy Is PaxMedica (PXMD) Stock Up 57% Today?investorplace.com - November 22 at 11:02 AMPaxMedica News of FDA Type-B Meeting Shared in Audio Broadcastfinance.yahoo.com - November 21 at 9:38 AMWhy Is PaxMedica (PXMD) Stock Down 40% Today?investorplace.com - November 20 at 4:10 PMPaxMedica, Inc.: PaxMedica Announces Pricing of $7.0 Million Public Offeringfinanznachrichten.de - November 20 at 12:59 PMCrude Oil Gains Over 2%; PaxMedica Shares Plungemarkets.businessinsider.com - November 20 at 12:59 PMWhy PaxMedica Stock (PXMD) Is Down Nearly 40% Todaymsn.com - November 20 at 12:59 PMPaxMedica Announces Pricing of $7.0 Million Public Offeringfinance.yahoo.com - November 20 at 12:59 PMPaxMedica, Inc. (PXMD) Stock Price, News, Quote & History - Yahoo Financeca.finance.yahoo.com - November 18 at 1:48 AMPaxMedica Releases Q3 2023 Financial Report, Corporate Updatefinance.yahoo.com - November 17 at 3:47 PMPaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Datafinance.yahoo.com - November 17 at 10:47 AMPaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business Updatefinance.yahoo.com - November 15 at 8:33 PMWhat's Going On With PaxMedica Stock Today?msn.com - November 14 at 6:29 PMmarketbeat.com - November 14 at 10:39 AMPaxMedica CMO Featured in Latest Bell2Bell Podcast Releasefinance.yahoo.com - November 10 at 10:57 AMPaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell Podcastfinance.yahoo.com - November 9 at 12:55 PMPaxMedica Phase 2 Study Results Published in Peer-Reviewed Journalfinance.yahoo.com - November 9 at 12:55 PM Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. PXMD Media Mentions By Week PXMD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMD News Sentiment▼-0.180.32▲Average Medical News Sentiment PXMD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMD Articles This Week▼51▲PXMD Articles Average Week Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PTPI News SNGX News KZIA News DRUG News ENSC News SNPX News LMDX News GTBP News CPHI News SONN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PXMD) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
